Promising future therapies for asthma

International Immunopharmacology

Volumn 23, Issue 1, 2014, Pages 373-377

  Stokes, Jeffrey R ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Asthma; Cytokines; LABA; LAMA

Indexed keywords

BENRALIZUMAB; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRODALUMAB; BRONCHODILATING AGENT; ENOKIZUMAB; ETANERCEPT; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LEBRIKIZUMAB; LONG ACTING DRUG; MEPOLIZUMAB; MONOCLONAL ANTIBODY; MUSCARINIC AGENT; PHOSPHODIESTERASE INHIBITOR; PITRAKINRA; TRALOKINUMAB; TUMOR NECROSIS FACTOR ALPHA; CORTICOSTEROID; CYTOKINE;

ARTICLE; ASTHMA; BRONCHIAL THERMOPLASTY; HUMAN; IMMUNOTHERAPY; INVASIVE PROCEDURE; META ANALYSIS (TOPIC); NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); AIRWAY OBSTRUCTION; ANIMAL; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; EOSINOPHIL; HEALTH CARE QUALITY; HYPERTHERMIC THERAPY; IMMUNOLOGY; SMOOTH MUSCLE; SURGERY;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AIRWAY OBSTRUCTION; ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; BRONCHODILATOR AGENTS; CYTOKINES; DRUG THERAPY, COMBINATION; EOSINOPHILS; HUMANS; HYPERTHERMIA, INDUCED; MUSCARINIC AGONISTS; MUSCLE, SMOOTH; STANDARD OF CARE;

EID: 84910649015     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.05.032     Document Type: Article

References (41)

1. S.S. Braman The global burden of asthma Chest 130 1 Suppl. Jul. 2006 4S 12S
2. NHLBI National asthma education and prevention program Expert Panel Report 3: guidelines for the diagnosis and management of asthma Full report 2007 vol 120 2007 National Heart, Lung and Blood Institute Bethesda, MD 1 417
3. E.D. Bateman, P.M. O'Byrne, W.W. Busse, J. Lötvall, E.R. Bleecker, and L. Andersen Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone Thorax 69 4 Apr. 2014 312 319 [Epub 2013 Nov 19]
4. W.W. Busse, P.M. O'Byrne, E.R. Bleecker, J. Lötvall, A. Woodcock, and L. Andersen Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >= 12 years old with asthma: a randomised trial Thorax 68 6 Jun. 2013 513 520 [Epub 2013 Feb 25]
5. A. Woodcock, E.R. Bleecker, J. Lötvall, P.M. O'Byrne, E.D. Bateman, and H. Medley Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial Chest 144 4 Oct. 2013 1222 1229
6. S.P. Peters, S.J. Kunselman, N. Icitovic, W.C. Moore, R. Pascual, and B.T. Ameredes National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma N Engl J Med 363 18 Oct. 28 2010 1715 1726 [Epub 2010 Sep 19]
7. E.D. Bateman, O. Kornmann, P. Schmidt, A. Pivovarova, M. Engel, and L.M. Fabbri Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma J Allergy Clin Immunol 128 2 Aug. 2011 315 322
8. T. Fardon, K. Haggart, D.K. Lee, and B.J. Lipworth A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma Respir Med 101 6 Jun. 2007 1218 1228 [Epub 2006 Dec 18]
9. H.A. Kerstjens, B. Disse, W. Schröder-Babo, T.A. Bantje, M. Gahlemann, and R. Sigmund Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial J Allergy Clin Immunol 128 2 Aug. 2011 308 314 [Epub 2011 Jun 2]
10. H.A. Kerstjens, M. Engel, R. Dahl, P. Paggiaro, E. Beck, and M. Vandewalker Tiotropium in asthma poorly controlled with standard combination therapy N Engl J Med 367 13 Sep. 27 2012 1198 1207 [Epub 2012 Sep 2]
11. L.M. Fabbri, P.M. Calverley, J.L. Izquierdo-Alonso, D.S. Bundschuh, M. Brose, and F.J. Martinez Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials Lancet 374 9691 Aug. 29 2009 695 703
12. L.G. Franciosi, Z. Diamant, K.H. Banner, R. Zuiker, N. Morelli, and I.M. Kamerling Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials Lancet Respir Med 1 9 Nov. 2013 714 727 [Epub 2013 Oct 25. PMID: 24429275]
13. M.M. Wahidi, and M. Kraft Bronchial thermoplasty for severe asthma Am J Respir Crit Care Med 185 7 Apr. 1 2012 709 714 10.1164/rccm.201105-0883CI [Epub 2011 Nov 10. Review]
14. G. Cox, J.D. Miller, A. McWilliams, J.M. Fitzgerald, and S. Lam Bronchial thermoplasty for asthma Am J Respir Crit Care Med 173 9 May 1 2006 965 969 [Epub 2006 Feb 2. PMID: 16456145]
15. G. Cox, N.C. Thomson, A.S. Rubin, R.M. Niven, P.A. Corris, and H.C. Siersted Asthma control during the year after bronchial thermoplasty N Engl J Med 356 13 Mar. 29 2007 1327 1337
16. N.C. Thomson, A.S. Rubin, R.M. Niven, P.A. Corris, H.C. Siersted, and R. Olivenstein Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial BMC Pulm Med 11 Feb. 11 2011 8
17. I.D. Pavord, G. Cox, N.C. Thomson, A.S. Rubin, P.A. Corris, and R.M. Niven Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma Am J Respir Crit Care Med 176 12 Dec. 15 2007 1185 1191 [Epub 2007 Sep 27]
18. M. Castro, A.S. Rubin, M. Laviolette, J. Fiterman, M. De Andrade Lima, and P.L. Shah Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial Am J Respir Crit Care Med 181 2 Jan. 15 2010 116 124 [Epub 2009 Oct 8]
19. M.E. Wechsler, M. Laviolette, A.S. Rubin, J. Fiterman, Lapa e Silva Jr., and P.L. Shah Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma J Allergy Clin Immunol 132 6 Dec. 2013 1295 1302 10.1016/j.jaci.2013.08.009 [Epub 2013 Aug 30]
20. G.J. Rodrigo, H. Neffen, and J.A. Castro-Rodriguez Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review Chest 139 1 2011 Jan 28 35 10.1378/chest.10-1194 [Epub 2010 Aug 5]
21. J. Bousquet, S. Wenzel, S. Holgate, W. Lumry, P. Freeman, and H. Fox Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma Chest 125 4 Apr. 2004 1378 1386
22. C. Brightling, M. Berry, and Y. Amrani Targeting TNF-alpha: a novel therapeutic approach for asthma J Allergy Clin Immunol 121 1 Jan. 2008 5 10 [quiz 11-2. Epub 2007 Nov 26]
23. S.T. Holgate, M. Noonan, P. Chanez, W. Busse, L. Dupont, and I. Pavord Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial Eur Respir J 37 6 Jun. 2011 1352 1359 [Epub 2010 Nov 25]
24. S.E. Wenzel, P.J. Barnes, E.R. Bleecker, J. Bousquet, W. Busse, and S.E. Dahlén A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma Am J Respir Crit Care Med 179 7 Apr. 1 2009 549 558 [Epub 2009 Jan 8]
25. C.K. Oh, D. Raible, G.P. Geba, and N.A. Molfino Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma Inflamm Allergy Drug Targets 10 3 Jun. 2011 180 186
26. C.K. Oh, R. Leigh, K.K. McLaurin, K. Kim, M. Hultquist, and N.A. Molfino A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma Respir Res 14 Sep. 19 2013 93
27. W.W. Busse, S. Holgate, E. Kerwin, Y. Chon, J. Feng, and J. Lin Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma Am J Respir Crit Care Med 188 11 Dec. 1 2013 1294 1302 10.1164/rccm.201212-2318OC
28. P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, and L. Brannick A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am J Respir Crit Care Med 176 11 Dec. 1 2007 1062 1071 [Epub 2007 Sep 13]
29. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 10 Mar. 5 2009 985 993
30. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 10 Mar. 5 2009 973 984
31. Erratum in N Engl J Med 364 6 Feb. 10 2011 588
32. P. Haldar, C.E. Brightling, A. Singapuri, B. Hargadon, S. Gupta, and W. Monteiro Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis J Allergy Clin Immunol 133 3 Mar. 2014 921 923 [Epub 2014 Jan 10]
33. I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, and O.N. Keene Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Lancet 380 9842 Aug. 18 2012 651 659
34. Y. Liu, S. Zhang, D.W. Li, and S.J. Jiang Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials PLoS One 8 3 2013 e59872 [Epub 2013 Mar 27]
35. Erratum in PLoS One 8 6 2013
36. M. Laviolette, D.L. Gossage, G. Gauvreau, R. Leigh, R. Olivenstein, and R. Katial Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia J Allergy Clin Immunol 132 5 Nov. 2013 1086 1096 [e5. Epub 2013 Jul 16]
37. E. Piper, C. Brightling, R. Niven, C. Oh, R. Faggioni, and K. Poon A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma Eur Respir J 41 2 Feb. 2013 330 338 [Epub 2012 Jun 27]
38. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron Lebrikizumab treatment in adults with asthma N Engl J Med 365 12 Sep. 22 2011 1088 1098 [Epub 2011 Aug 3]
39. M. Noonan, P. Korenblat, S. Mosesova, H. Scheerens, J.R. Arron, and Y. Zheng Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids J Allergy Clin Immunol 132 3 Sep. 2013 567 574 [e12. Epub 2013 May 29]
40. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, and F. Skobieranda Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 26 Jun. 27 2013 2455 2466 [Epub 2013 May 21]
41. S. Wenzel, D. Wilbraham, R. Fuller, E.B. Getz, and M. Longphre Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Lancet 370 9596 Oct. 20 2007 1422 1431